AVR — Anteris Technologies Global Corp. Common Stock

Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on NASDAQ. It is led by Wayne Geoffrey Paterson, based in Toowong Tower, Toowong, QLD, Australia, 4066, with about 136 employees. Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Latest reported AVR revenue for 2025-09-30 was $429.0K. Net income was -$22.2M. Revenue was down 30.6% from 2025-06-30 to 2025-09-30. AVR currently screens at market cap $287.2M.

Use this AVR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AVR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AVR SEC filings page. Lician reads the product cache first so this HTML stays unique to Anteris Technologies Global Corp. Common Stock even when a live quote feed is slow.